top of page
Our Pipeline
A platform organized by therapeutic modality.
TheraStel is advancing modular bioelectric therapeutic collections built on proprietary SIHD delivery.
Our Collections
Collection 1
SIHD-K Activator Platform
Potassium Ion-Channel Activators
A bioelectric therapeutic platform leveraging potassium ion-channel activators delivered via SIHD to modulate tumor membrane potential and disrupt pathological signaling.
Lead Program
SIHD-CZX
Indication: Chemo-resistant breast cancer
​
Status: Preclinical
Future Program
SIHD-MX
Indication: Chemo-resistant ovarian cancer
​
Status: Research
Collection 2
SIHD-Ca Activator Platform
Calcium Ion-Channel Activators
A platform focused on calcium ion-channel activation to influence intracellular signaling and bioelectric states across multiple therapeutic areas.
Future Program
SIHD-CBD
Indication: Colon cancer
​
Status: Research
bottom of page